Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for preventing and/or treating inflammatory storm and preparation and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of composition and medicine, which is applied in the field of medicine, can solve the problems that the active ingredient of baicalin flavonoids has not been reported, etc.
Pending Publication Date: 2022-01-14
BEIJING WEHAND BIO PHARMA CO LTD +1
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is no report on the application of the active ingredients of Scutellaria baicalensis in the preparation of drugs for preventing and treating inflammatory storms.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0055] According to the ratio of drug to lipid (1:3.5, w / w), weigh 1 g of the pharmaceutical composition (the mass ratios of baicalein, wogonin, and scutellarin A are respectively selected as 0.5:7:1 (ratio 1), 1.5:5:1 (ratio 2), 0.29:0.86:1 (ratio 3) and 0.43:0.57:1 (ratio 4) 3.5g of phospholipid S75, put in a rotary evaporator, add 20mL THF After the drug and phospholipid are completely dissolved, let it stand for 30 minutes, place it on a rotary evaporator, evaporate the solvent at 40°C, dry it under reduced pressure and vacuum for more than 12 hours, and scrape off the solid to obtain drug-phospholipid complexes with different drug ratios.
Embodiment 2
[0056] Embodiment 2, the preparation of self-microemulsion
[0057] Take ethyl oleate, Tween 80 and Transcutol HP by the mass ratio of 2:5:3, shake evenly, make blank self-microemulsion solution, add the medicinephospholipid complex prepared in embodiment 1 wherein, charging amount is 10% (taking the mass of blank milk as 100% dosage), put it in an air bath shaker, set the temperature at 25°C, and the rotation speed at 210 rpm, shake and dissolve completely, and then get self-microemulsions with different drug ratios.
Embodiment 3
[0058] Embodiment 3, the pharmacodynamic experiment of pharmaceutical composition and self-microemulsion
[0061] Wogonin API (batch number 111514-201706, China National Institutes for Food and Drug Control), Melaleucain A API (batch number PRF10030442, Chengdu Pufarui Technology Development Co., Ltd.), Lipopolysaccharides from Escherichia coli 055:B5 (SIGMA); chlorineSodiumchloride injection (Sichuan Kelun Pharmaceutical Co., Ltd.); Mouse IL-6 ELISA Kit (Elabscience); Mouse Inflammation Panel, Mouse Cytokine Release Syndrome Panel, Mouse Proinflammatory Chemokine Panel (Biolegend); C57 BL / 6 male mice, 18 -22g, (Beijing Huafukang Biotechnology Co., Ltd.); XS 105DU 1 / 100,000 electronic balance (METTLER TOLEDO); 1-14 centrifuge (SIGMA); VORTEX-2 GENIE vortex instrument (Scientific Industries ); Flow cytometer C6 (BD Accuri).
[0062] (2)...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical composition for preventing and / or treating inflammatory storm, a preparation and application thereof. The pharmaceutical composition is prepared from baicalein, wogonin and oroxylin A, and the mass ratio of the baicalein to the wogonin to the oroxylin A is (0.25-1.5):(0.5-7):1. The self-microemulsion provided by the invention comprises the following components: a drugphospholipid complex, an oil phase, an emulsifier and a co-emulsifier, wherein the drugphospholipid complex is formed by compounding the medicine composition and a phospholipid material. Experimental results show that in an LPS-induced systemic inflammationstorm mouse model, the composition of the baicalein, the wogonin and the oroxylin A and the self-microemulsion preparation of the composition have the effects of inhibiting mouse cytokinestorm to different degrees. The pharmaceutical composition for preventing and / or treating inflammatory storm, the preparation and the application thereof provide a safe, effective and economical solution for clinical treatment of inflammatory storm.
Description
technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for preventing and / or treating inflammatory storm, its preparation and application. Background technique [0002] Inflammatory storm is an excessive immune response and inflammatory response of the body to external stimuli, characterized by the excessive proliferation of T cells and macrophages and the rapid release and overexpression of inflammatory cytokines. Inflammatory storms can be caused by many infectious or noninfectious diseases, such as influenza, new coronary pneumonia (COVID-19), Middle East respiratory syndrome (MERS-CoV), atypical pneumonia (SARS), familial hemophagocytic syndrome, sepsis, systemic Juvenile idiopathic arthritis (sJIA), chimeric antigen receptor (CAR)-T cell therapy and lupus erythematosus, etc. [0003] The inflammatory storm phenomenon caused by respiratory virus infection such as influenza virus and coronavirus is...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More